Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children
- 1 June 2012
- Vol. 30 (26) , 3975-3981
- https://doi.org/10.1016/j.vaccine.2011.12.022
Abstract
No abstract availableKeywords
Funding Information
- Intramural Research Program of the National Institutes of Allergy and Infectious Diseases (NIAID)
- National Institutes of Health
This publication has 41 references indexed in Scilit:
- The cDNA-derived Investigational Human Parainfluenza Virus Type 3 Vaccine rcp45 Is Well Tolerated, Infectious, and Immunogenic in Infants and Young ChildrenThe Pediatric Infectious Disease Journal, 2011
- An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 yearsInfluenza and Other Respiratory Viruses, 2011
- PHASE-I STUDY MEDI-534, OF A LIVE, ATTENUATED INTRANASAL VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS AND PARAINFLUENZA-3 VIRUS IN SEROPOSITIVE CHILDRENThe Pediatric Infectious Disease Journal, 2009
- Parainfluenza Virus Infection of Young Children: Estimates of the Population-Based Burden of HospitalizationThe Journal of Pediatrics, 2009
- Current Status of Vaccines for Parainfluenza Virus InfectionsThe Pediatric Infectious Disease Journal, 2008
- Parainfluenza VirusesThe Pediatric Infectious Disease Journal, 2006
- Evaluation of a Live, Cold‐Passaged, Temperature‐Sensitive, Respiratory Syncytial Virus Vaccine Candidate in InfancyThe Journal of Infectious Diseases, 2000
- Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infantsThe Pediatric Infectious Disease Journal, 1996
- Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3Journal of General Virology, 1993
- Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton ratsVaccine, 1991